Latest Ionis News & Updates

See the latest news and media coverage for Ionis. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Ionis

RNA- and DNA-targeted medicines developer

ionis.com
Headquarters
Carlsbad, United States
Founded year
1989
Company type
Public company
Number of employees
500–1,600

Last updated

Latest news about Ionis

Company announcements

  • Ionis

    Ionis presents AxD study data at AAN Meeting

    They gathered in Chicago, shared positive pivotal data on Alexander Disease treatment, and discussed neurology programs with providers and advocates.

  • Ionis

    Ionis reports Q1 2026 financial results

    Revenue rises 87% to $246M. TRYNGOLZA sales hit $27M. Olezarsen sNDA accepted for priority review. Guidance improved.

  • Ionis

    GSK announces FDA Priority Review for bepirovirsen

    FDA grants Breakthrough Therapy Designation for the Ionis-partnered drug targeting chronic hepatitis B. PDUFA date is October 26, 2026.

  • Ionis

    Ionis publishes 2025 Corporate Responsibility Report

    It highlights milestones in RNA medicines, pipeline progress, employee empowerment, community support, and sustainability efforts including Climate Risk Assessment.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Ionis

Track Ionis and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Ionis competitors & trending companies

Browse news for competitors to Ionis and other trending companies.